The Canonsburg headquarters of Viatris. (PAUL J. GOUGH/PBT)

By Mitra Nourbakhsh, Pittsburgh Business Times

The DOJ announced on Tuesday that it had informed Canonsburg-based pharmaceuticals company Viatris that, Mylan, which is now part of Viatris, as well as Mylan’s former president Rajiv Malik are no longer under investigation for alleged antitrust practices. The decision effectively clears Mylan, which in 2020 merged with Pfizer unit Upjohn to create Viatris, of any potential charges related to the probe.

The antitrust division of the Department of Justice had been investigating Mylan and other major pharmaceutical companies for alleged anticompetitive business practices in fixing prices of generic drugs. Viatris said in a release that the outcome affirms its longstanding position: That there was “no evidence of wrongdoing on the part of Mylan or its employees.”

The company, which has global centers in Pittsburgh, Shanghai, and Hyderabad, India, is known for producing generic and branded drugs like erectile dysfunction treatment Viagra. Although the DOJ investigation has been dropped, Viatris continues to battle a number of civil lawsuits.

“The company is pleased to put these DOJ investigations behind it and will continue to move forward to vigorously defend itself against the remaining civil lawsuits pertaining to these matters,” Viatris said in a release.

The news comes just days after Viatris was named to Time Magazine’s inaugural edition of World’s Most Sustainable Companies list.

Viatris joined American Eagle as the only two Pittsburgh companies on the list.

Viatris came in at No. 263 on the list, which was made of up of 500 companies deemed to be the biggest leaders in corporate responsibility.

Mitra Nourbakhsh is a student at Northwestern University and one of 10 Pittsburgh Media Partnership summer interns. Mitra is interning with the Pittsburgh Business Times.